Tranexamic Acid is a synthetic derivative of lysine, which is a commonly used hemostatic drug in clinical practice, which exerts hemostasis by inhibiting the dissolution of fibrin. Tranexamic acid can inhibit plasmin, plasminogen and fibrin binding, thereby strongly inhibiting the breakdown of fibrin caused by plasmin, in addition, in the presence of anti-plasmin such as macroglobulin in the serum, the antifibrinolytic effect of tranexamic acid is more obvious.

The chemical structure of tranexamic acid is similar to lysine, which can competitively inhibit the adsorption of plasminogen on fibrin, prevent its activation, protect fibrin from being degraded and dissolved by plasmin, and finally achieve hemostatic effect. It is suitable for the treatment of various bleeding caused by acute or chronic, localized or systemic primary fibrinolysis, such as obstetric hemorrhage, renal hemorrhage, prostatic hypertrophy hemorrhage, hemophilia, tuberculosis hemorrhage, gastric bleeding, bleeding after liver, lung, spleen and other visceral surgery; It can also be used for abnormal bleeding during surgery.

Specifications of Tranexamic Acid CAS 1197-18-8

Items Specifications Results

Appearance White crystalline powder White crystalline Powder

PH 7.0～8.0 7.2

Heavy metals ≤10ppm ＜10ppm

Loss on drying ≤0.5% 0.22%

Sulphated ash ≤0.1% 0.05%

Assay 99.0%～101.0% 99.8%

Parameters of Tranexamic Acid CAS 1197-18-8

Product parameters

Cas number: 1197-18-8

Appearance: White crystalline powder

Purity: 99%min

Package details: 1kg/foil bag; 25kg/drum

Brand: Fortunachem

There are many active pharmaceutical ingredient manufacturers, but we are one of the best choices for you.